Wednesday, February 25, 2009

First Baseball and Softball Cleats Receive APMA Seal of Acceptance

First Baseball and Softball Cleats Receive APMA Seal of Acceptance

RINGOR® baseball and fastpitch softball metal spikes and non-metal cleats are the first to receive the prestigious Seal of Acceptance of the American Podiatric Medical Association for allowing normal foot function and promoting good foot health.

Wilsonville, Oregon (PRWEB) February 25, 2009 -- Baseball and women's fastpitch softball cleat manufacturer, RINGOR®, has received the Seal of Acceptance from the American Podiatric Medical Association (APMA). The Seal is awarded to products that exhibit "quality and effectiveness in allowing for normal foot function and promote good foot health."

"Footwear properly designed to protect feet during sporting events should always include features such as correct weight distribution, a firm heel counter, and adequate traction and control," said Ross E. Taubman, DPM, president of the American Podiatric Medical Association (APMA).

"RINGOR's selected models of footwear have demonstrated that they promote foot safety while participating in the sports of baseball and softball, which is why this line of products now holds the APMA's respected Seal of Acceptance for maintaining quality foot health."

RINGOR® product lines that have received the APMA Seal of Acceptance (https://www.ringor.com/baseball-softball-cleats-receive-apma-acceptance.asp) include the following:

Softball Cleats (https://www.ringor.com/softball.asp)

Diamond Gem™ Softball Spike Line

Diamond Gem™ Softball Cleat Line

Diamond Star™ Softball Spike Line

Diamond Star™ Softball Cleat Line    

Baseball Cleats (https://www.ringor.com/baseball.asp)

Diamond Streak™ Baseball Spike Line

Classics™ Baseball Spike Line

In 1983, RINGOR® pioneered the first pattern that was designed to reduce bone bruising and awkward flex points by creating the Ring-Grip™ Cleat Pattern, the baseball and fastpitch softball footwear industry's first circular cleat pattern. Ring-Grip™ is the heart of the RINGOR® brand and is the technology in which the company was founded. It has also been the genesis for all present and future metal and non-metal cleats.

This design was developed from a need for a footwear company to respond to players who complained about uncomfortable baseball and fastpitch softball shoes. Traditional design was turned on its ear when RINGOR® changed the placement of the cleats. To reduce pressure on sensitive foot bones, RINGOR® made the midsection of the shoe rigid to reduce stress on the arch and slightly raised the heel, placing the player on the balls of their feet. With the addition of a full-length EVA midsole, the result is a shoe that is comfortable to wear and more responsive to player movements.

RINGOR's® Ring-Grip™ pattern is ideal for serious players who play at a high intensity as well as younger players whose feet are still growing. The pattern aids in helping to reduce injuries such as bone bruising and spiral tendon, ligament and bone injuries caused by cleats or spikes "hanging up" during play.

This pattern allows the athlete to quickly grip and move in multiple directions at high bursts of speed. These movements categorize the common movements used in fast paced, stop/start sports like baseball and women's fastpitch softball.

"We place a great deal of emphasis on creating a safer, more comfortable and higher performing product for baseball and softball athletes and the Seal of Acceptance is proof of that passion," says Gary Killingsworth, RINGOR's® Marketing Director. "We are extremely pleased to have RINGOR® products recognized by the APMA."

RINGOR® is a manufacturer of baseball cleats (https://www.ringor.com/baseball.asp) and women's fastpitch softball footwear (https://www.ringor.com/softball.asp), apparel, bags and accessories. The company, headquartered in Wilsonville, Oregon, was founded in 1983. RINGOR® is a direct sales company, whose products are sold through its website, phone sales or through RINGOR's Team Sales (https://www.ringor.com/team.asp) department.

Contact:

Gary Killingsworth, Marketing Director

RINGOR®

800-746-4670 Ext. 4011

###



Contact Information Gary Killingsworth

RINGOR

http://www.ringor.com

800-746-4670



Tuesday, February 24, 2009

Study Shows Simple Measures May Help Prevent Sudden Death Event in Young Athletes

Study Shows Simple Measures May Help Prevent Sudden Death Event in Young Athletes

A blunt, non-penetrating hit to the chest from a baseball or hockey puck at just the right time could cause sudden death in an athlete. The condition, commotio cordis and its prevention were investigated in the March/April issue of Sports Health: A Multidisciplinary Approach

Rosemont, IL (Vocus) February 24, 2009 -- A blunt, non-penetrating hit to the chest from a baseball or hockey puck at just the right time could cause sudden death in an athlete. The condition, commotio cordis and its prevention were investigated in the March/April issue of Sports Health (www.sportshealthjournal.org): A Multidisciplinary Approach

According to the study, more than 190 cases of commotio cordis (www.sportshealthjournal.org) have been reported in the United States with 47% occurring during athletic participation. Twenty percent of reported sudden-death cases in young athletes are attributed to commotio cordis, second only to hypertrophic cardiomyopathy or thickened heart muscles. This number may be considerably higher due to lack of recognition and underreporting.

The authors' research suggests that young males, ages 4 to 18, appear to be at the greatest risk. This might be attributable to an increase in the flexibility of their chest wall, although more research still needs to be conducted to confirm this conclusion.

"Twenty-five percent of the reported cases were in youth baseball where pitches averaged 30-50 mph upon time of impact with an individual's chest. Our research illustrates that the harder the projectile and the straighter the path to the chest, the greater the chance for commotio cordis to occur," said lead author, Mark S. Link, MD of Tufts Medical Center in Boston, MA.

The increased use of chest protectors and soft, age appropriate "safety" baseballs are now recommended in youth baseball leagues by the U.S. Consumer Product Safety Division to reduce commotio cordis risk and other injuries. "The best preventative measures may be changes in the rules, i.e. eliminating blocking shots with the chest in lacrosse and hockey players and coaching players to protect their chests," said Link. "Increased awareness of commotio cordis is also imperative, especially in those that may be first responders such as parents, coaches, game officials and medical personnel. In addition, with the increased use of Automated External Defibrillators (AED) at athletic events, commotio cordis survival rates will improve."

Published bimonthly, Sports Health is a collaborative publication from the American Orthopaedic Society for Sports Medicine (www.sportshealthjournal.org) (AOSSM), the American Medical Society for Sports Medicine (AMSSM), the National Athletic Trainers' Association (NATA), and the Sports Physical Therapy Section (SPTS). Other organizations participating in the publication include the American Academy of Pediatrics and the American Osteopathic Academy of Sports Medicine (AOASM). For more information on the publication or to submit a manuscript, visit www.sportshealthjournal.org

For additional questions, please contact Lisa Weisenberger, AOSSM Director of Communications at 847-292-4900 or send an e-mail to lisa @ aossm.org

###



Contact Information Lisa Weisenberger

AOSSM Director of Communications

http://www.sportshealthjournal.org

847-292-4900



The Nike+ iPod Sensor Can Be Used by Any Runner with the New Bean Pod.*

The Nike+ iPod Sensor Can Be Used by Any Runner with the New Bean Pod.*

Runners and joggers can track pace, time, distance, and more with Nike+ iPod technology, even when they aren't wearing Nike shoes. The Bean Pod by Red Rock Products, Inc will adapt the Nike+ iPod technology to whatever shoe the user is wearing.

Orange, CA (PRWEB) February 24, 2009 -- Red Rock Products, Inc. has released their Universal Nike+ Sensor adapter, called "the BEAN POD."

The compact Bean Pod allows runners & walkers the ability to use their Nike+ sensor on any non Nike+ brand of running shoes.

A few years ago the wildly popular Apple iPod teamed up with Nike to offer a system that allows iPod users the ability to receive audio feedback on their running. The system gives the runner their pace, time, distance and calories burned, with various celebrities offering positive commentary. The problem has been for many that this system only works with selected Nike+ shoes, leaving iPod users that did not own Nike+ shoes eating their dust.

The American cry of freedom rings true once again with the Bean Pod (http://www.bestinsoles.com/Bean-Pod-2-Pack-Universal-Nike-iPod-Sensor-Holder_p_955.html). The Bean Pod allows anyone to use the IPod / Nike+ system on other makes of running shoes; this includes many Nike shoes that do not have the "sensor option."

The Bean Pod fills a real need as the numbers of people that enjoy running with an iPod far outnumber the people that have the Nike+ version on the shoes.

The Bean Pod is designed by a runner for runners. Inventor and patent holder, Tom Amon, often asks himself, "Isn't there a better way to do this," and it was that question that led him to develop a handmade adapter to use on his non Nike shoes. After making several for his wife and other running buddies, he realized that there was a large market for likeminded iPod runners. Tom strongly feels that, "Everyone should have access to the Nike+ iPod Sensor technology so that they can make the most of their exercise."

The Bean Pod's simple design allows users to simply lace the Bean Pod into their shoelaces and then insert the (Bean Shaped) Nike sensor into a back pocket. The sensor is then held securely in place allowing a clear signal the iPod receiver.

About Red Rock Products, Inc:

Red Rock Products, Inc is dedicated to providing athletes and running enthusiasts with products that promote fitness and foot health. From insoles, to blister and wound care, to sports accessories like the Bean Pod, we the one source for foot care. We encourage people to be active, stay healthy, and keep their feet feeling as great as they do with products from Red Rock.

It's important for runners and joggers to have healthy feet. Sports Insoles (www.bestinsoles.com) can provide the cushioning and support necessary for comfortable exercise.

The Bean Pod is available to consumers at www.FitnessToys.com.

For a FREE SAMPLE, Qualified Press can contact:

Leah Selway - Dir. Business Development

Phone: (Toll Free) 888-4-Red Rock | 888-473-3762

Red Rock Products, Inc.

2430 N. Glassell St, Suite D

Orange, California 92865

www.RedRockProductsInc.com

Digital Images for Print: www.FitnessToys.com/BeanPod

*IPod is a trademark of Apple, Inc. Nike is a trademark of Nike, Inc. and its affiliated companies.

###



Contact Information Tom Amon

Red Rock Products, Inc

http://www.fitnesstoys.com

888-473-3762



Monday, February 23, 2009

Achy Joints Relief Breakthrough Announced to U.S. Athletes

Achy Joints Relief Breakthrough Announced to U.S. Athletes

Achy joints (http://www.flexnow.us) relief breakthrough, FlexNow® a natural dietary supplement with a new approach for painful joints releases its clinical trial results to U.S. athletes.

Egg Harbor Twp, NJ (PRWEB) February 23, 2009 -- Achy joints (http://www.flexnow.us) relief breakthrough, FlexNow® a new approach for painful joints is the only all natural dietary supplement containing shea triterpenes. Shea triterpenes, under the name BSP-201, was the subject of a double-blind randomized placebo controlled parallel group clinical study with the aim to evaluate the anti-inflammatory and analgesic (pain relief) effects in humans. FlexNow manufacturer and distributor, BSP Pharma, excitedly announce the findings from this clinical study to suffering U.S. athletes.

The study demonstrates that the oral administration of shea triterpenes (BSP-201) reduces achy joints and muscle tenderness hence pain and the related inflammatory process associated with post-exercise muscle soreness. This is relevant to arthritic pain as it is the same underlying inflammatory process in both cases. The abstract can be found at http://www.flexnow.us/sports/

Shea triterpenes, the sole ingredient in FlexNow, comes from the pit of the shea fruit found in West Africa and are distinctive in the botanical world for their ability to reduce joint specific inflammation and relieve achy joints. Unlike glucosamine, shea triterpenes target joint specific inflammation making it one of the most powerful inflammation fighters of any known botanical.

"For athletes who've been pounding the hardwood, asphalt, Astroturf and grasses for years, achy joints, painful joints and joint specific inflammation can gradually or suddenly appear and become an overwhelming adversary," says joint health educator and BSP Pharma President, Len Smith.

"We know that poor joint health is triggered by circulatory blockage in the joint blood vessels which degrades nutrient flow into the joint cartilage," says Smith. "Improvements in joint health are only possible when fats and nutrients can again freely flow through the blocked blood vessels, and this is helped considerably by reducing joint specific inflammation."

"FlexNow has truly changed my life in a way I did not think possible. I am able to live my life like a normal person without the constant nuisance of arthritic pain in my knee. I have been recommending it to all my clients and they love it too!" reports C.J. Murphy, MFS, National Powerlifting Champion 2006, and co-owner of Total Performance Sports voted one of American's 20 Best Gyms by Men's Health Magazine, 2008 & 2005.

FlexNow has many anecdotal validations from athletes such as world class cyclists, professional football players, weightlifters, and marathoners who have gotten their games back and are able to compete fully in their sport once again.

Additionally, FlexNow™ Joint Formula was one of only seven dietary supplements accepted by the FDA in 2004, meeting all the safety and toxicology requirements under the Dietary Supplement Health and Education Act. And it was the Best of Supplements winner in 2008 by Better Nutrition and comes with a complete relief or complete refund guarantee.

Achy joints (http://www.flexnow.us) relief found with FlexNow is a nutraceutical by BSP Pharma Inc., a subsidiary of BSP Pharma A/S of Denmark, based in Egg Harbor Township, NJ, and was formed in 2005 to bring the remarkable shea ingredient health products to market. BSP's CEO and President Leonard P. Smith has held senior level positions in the nutraceutical and pharmaceutical industry for more than 20 years. For product availability and additional information visit the company's website http://www.flexnow.us/aboutus/.

###



Contact Information Kelly Fay

The PR Group Inc

http://www.flexnow.us

727-447-4992



Friday, February 20, 2009

Baltimore LASIK Eye Surgeon Walter J. Stark, M.D. of the Wilmer Eye Institute at Johns Hopkins Joins Trusted LASIK Surgeons Directory

Baltimore LASIK Eye Surgeon Walter J. Stark, M.D. of the Wilmer Eye Institute at Johns Hopkins Joins Trusted LASIK Surgeons Directory

Trusted LASIK Surgeons announced today that LASIK and refractive eye surgery expert Doctor Walter Stark of the Wilmer Laser Vision Center at Johns Hopkins in Baltimore, Maryland has joined the Trusted LASIK Surgeons Directory, an informational resource for consumers looking for vision correction and improvement through laser and lasik eye surgery or another refractive eye surgery procedure. Dr. Stark's practice primarily serves patients seeking laser eye surgery throughout Maryland including Arlington, Bethesda, and Frederick, Washington D.C., Dover and Newark in Delaware, as well as surrounding states, and patients visiting from international locations.

Baltimore, MD (PRWEB) February 20, 2009 -- Trusted LASIK Surgeons (http://www.trustedlasiksurgeons.com/index.htm) announced today that Walter J. Stark, M.D. (http://trustedlasiksurgeons.com/baltimore_lasik_surgeon_walter_stark_md.htm), of the Wilmer Laser Vision Center at Johns Hopkins in Baltimore, Maryland (http://www.hopkinsmedicine.org/wilmer/lasik) is listed in the Trusted LASIK Surgeons Directory (http://www.TrustedLASIKSurgeons.com), an informational resource for consumers looking to improve their vision through laser eye surgery or another refractive eye surgery procedure. Dr. Stark's practice primarily serves patients seeking improve uncorrected visual acuity through LASIK and laser eye surgery in Baltimore, Arlington, Columbia, Rockville and Washington, D.C. areas (http://www.trustedlasiksurgeons.com/baltimore_lasik_surgeons.htm). Dr. Stark also treats patients seeking LASIK and other vision correction procedures throughout Maryland (http://trustedlasiksurgeons.com/maryland_lasik_surgeons.htm), as well as surrounding states and international countries.

Trusted LASIK Surgeons directory endeavors to list only those LASIK eye surgeons who are among the best in the United States. To accomplish this, Trusted LASIK Surgeons screens each eye surgeon based on experience, premier patient care, and professional credentials. Trusted LASIK Surgeons estimates that Dr. Stark's outstanding professional credentials place him among the top 1% of LASIK and refractive surgeons in the United States.

The most significant professional qualifications that set Dr. Stark apart from the majority of LASIK eye surgeons in the United States are based on his extensive research, teaching and consulting expertise. Dr. Stark serves as a Distinguished Professor of Ophthalmology and Director of the Stark-Mosher Center for Cataract and Corneal Diseases of The Wilmer Eye Institute Wilmer Eye Institute (http://www.hopkinsmedicine.org/wilmer) at the Johns Hopkins Medical Institutions, which is repeatedly ranked as the top eye care center in the nation in surveys by U.S. News & World Report and Ophthalmology Times. He has served as a principal investigator for 1 FDA study for vision correction lasers, has written 10 textbook chapters and textbooks, and has published over 400 scientific articles for major peer-reviewed eye journals. In addition, he serves in an editorial capacity for Ophthalmology Times and Ophthalmology World News. Dr. Stark has made over 400 presentations at major eye meetings throughout the world. He was the former chairman and is currently a consultant for the US Food and Drug Administration's (FDA) Ophthalmologic Devices Panel. He is also a consultant for the National Eye Institute, as well as many organizations dedicated to improving vision, including the Medical Eye Bank of Maryland, Tissue Eye Banks International, Project ORBIS, and the National Foundation for Eye Research among others. His considerable contributions to the field of refractive eye surgery have earned him the respect of his peers throughout the world.

In the course of helping patients improve their vision, Dr. Stark has performed thousands of LASIK eye surgery and laser vision correction procedures. With over 18 years of experience in laser vision surgery, including LASIK, as well as in other refractive surgery procedures such lens implants, Dr. Stark has the proven know-how to provide patients with the best care available.

Certified by the American Board of Ophthalmology, this highly qualified LASIK eye surgeon is an active member of many professional organizations. The American Academy of Ophthalmology, where he has served for several years as the Chairman of the Committee for Research and Regulatory Agencies and the Chairman for the Committee for Ophthalmic Technology Development, has honored him with an Achievement Award, a Life Achievement Honor Award, the Binkhorst Medal Lectureship and a Senior Honor Award. In addition, Dr. Stark is a member of the American Medical Association, the Cornea Society (formerly the Castroviejo Society), the International Society for Contact Lens Research, the Microbiology and Immunology Group, Ophthalmic Genetics Study Club, the Association for Research in Vision and Ophthalmology (ARVO), the Eye Study Club. Locally, he is a member of the Maryland Ophthalmological Society.

Dr. Stark's practice at The Wilmer Eye Institute at Johns Hopkins provides state-of-the-art patient care, including use of the IntraLase system for "All-Laser" or "Bladeless" LASIK, Wavefront Based ("Custom") LASIK and PRK, and the iLASIK procedure, which includes WaveScan Technology, IntraLase, and Visx Advanced CustomVue treatments. Dr. Stark treats a full range of vision problems including nearsightedness (myopia), farsightedness (hyperopia), astigmatism (blurred vision), and presbyopia. Dr. Stark offers not just LASIK and PRK (laser eye surgery procedures), but other procedures like RLE/CLE (lens implants), phakic implants, limbal relaxing incisions, and cataract lens implants procedures to ensure patients have a complete range of options when it comes to choosing the right procedure to improve their vision. Other eye doctors and eye surgeons commonly seek Dr. Stark to perform their LASIK or other refractive surgery procedure. In addition, new patients who have suffered problems from a LASIK eye surgery or another vision correction procedure performed by another surgeon regularly seek Dr. Stark to manage and treat their problems.

Dr. Stark's most treasured honor was the dedication of the Walter J. Stark, M.D. and Margaret C. Mosher Center for Cataract and Corneal Diseases. Margaret Mosher, his long-time patient and friend, made the Center possible through her generous donation. In addition, he has been recognized as one of Baltimore's "Top Doctors" by Baltimore magazine and one of Washington D.C. "Top Doctors" by Washingtonian magazine.

"Dr. Stark was among the first group of refractive eye surgeons in the world to perform Excimer laser surgery when he was the principle investigator for the VISX FDA Phototherapeutic study in the early 1990's," said James J. Salz, M.D., Chief Executive Officer of Trusted LASIK Surgeons. "He has made major contributions to the field of Excimer laser surgery and cataract surgery techniques through hundreds publications and lectures throughout the world. We are honored to have him as a member of the Trusted Lasik Surgeons Directory."

"Providing safe and effective refractive surgery is our goal. We are more conservative than many refractive surgeons and, therefore, will not offer you the surgery if you are not a good candidate," said Walter Stark, M.D. Distinguished Professor of Ophthalmology and Director of the Stark-Mosher Center for Cataract and Corneal Diseases of The Wilmer Eye Institute at The Johns Hopkins Medical Institutions.

Visit Baltimore, Maryland LASIK Surgeon Walter J. Stark, M.D. profile page at Trusted LASIK Surgeons (http://www.trustedlasiksurgeons.com/baltimore_lasik_surgeon_walter_stark_md.htm)

To learn more about Dr. Stark's refractive surgery practice, please visit Baltimore, MD, LASIK eye surgeon Walter J. Stark, M.D. at Wilmer Eye Institute (http://www.hopkinsmedicine.org/wilmer/employees/cvs/Stark.html)

For more on why consumers should consider surgeons listed in the Trusted LASIK Surgeons directory for their vision correction needs, please visit: Why choose a Surgeons from the Trusted LASIK Surgeon's Directory (http://www.trustedlasiksurgeons.com/why_use_a_trusted_lasik_surgeon.htm)

The screening process and standards used by Trusted LASIK Surgeons are located at How Are LASIK Surgeons Qualified at Trusted LASIK Surgeons? (http://www.trustedlasiksurgeons.com/how_are_lasik_surgeons_qualified_at_tls.htm)

To find a highly accomplished LASIK and refractive specialist in your local area who has been qualified and listed in the Trusted LASIK Surgeons directory, please visit Trusted LASIK Surgeons Directory (http://www.trustedlasiksurgeons.com/find_a_lasik_eye_surgeon.htm)

SOURCE: Trusted LASIK Surgeons

About Trusted LASIK Surgeons, Inc.

Trusted LASIK Surgeons, Inc. (Trusted LASIK Surgeons) is a premier LASIK, laser eye surgery, and refractive eye surgery directory service whose primary mission is to assist consumers in finding the best and most qualified LASIK and vision correction surgeons in their local area in the United States. To accomplish this, Trusted LASIK Surgeons uses a unique screening process where each prospective LASIK eye surgeon must meet the minimum required qualifications set by Trusted LASIK Surgeons. These qualifications for these doctors are based on experience (not just in LASIK but complete refractive care), research (including FDA approval studies for manufacturers and academic appointments at major universities), publications and lectures (to their peers, not to the public via infomercials) and patient care standards (treating other eye professionals and managing complications from patients first operated on by someone else). All refractive eye surgeons listed at Trusted LASIK Surgeons have qualified, been accepted, and have subscribed to our services. For more information on why we believe consumers interested in LASIK should consider an eye surgeon listed in the Trusted LASIK Surgeon's directory, please visit our website at www.TrustedLASIKSurgeons.com.

Trusted LASIK Surgeons, Inc.

(800) 483-8028

The Wilmer Laser Vision Center

The Wilmer Eye Institute has been performing laser vision correction since the early 1990's and has performed thousands of surgeries to date. Our facilities are state-of-the-art with the most technically advanced equipment designed to make your procedure as safe and efficient as possible. The Wilmer Laser Vision Center utilizes the iLASIK system which includes the VISX WaveScan Wavefront(tm) System, IntraLase FS(tm) Femtosecond Laser, and the VISX STAR S4 IR(tm) Excimer Laser for our laser vision correction procedures. Our laser vision correction surgeons are members of the Trusted LASIK Surgeons Directory. The Wilmer Eye Institute is repeatedly ranked as the top eye care center in the nation in surveys by U.S. News & World Report and Ophthalmology Times. The Wilmer Eye Institute has been a leader in laser vision care and has developed some of the earliest lasers for vision care and pioneered laser removal of corneal scars and laser treatment for corneal diseases. The Wilmer Eye Institute participated in the first clinical trials of laser correction for nearsightedness, farsightedness and wavefront technology and continues to participate in clinical trials for approvals of new advanced excimer laser software and technology. Wilmer is helping to develop the next generation of laser vision correction procedures. The laser surgeons at The Wilmer Laser Vision Center are full-time faculty members of The Johns Hopkins Hospital, Wilmer Eye Institute and are highly trained cornea experts who can help you to understand laser vision correction and its impact on your long-term vision health. The Wilmer Eye Institute trains more eye experts, are entrusted to perform more eye research than any other center and have contributed to amazing advances in eye care. For more information about the Wilmer Laser Vision Center, please visit: www.hopkinsmedicine.org/wilmer/lasik.

The Wilmer Laser Vision Center at Green Spring Station

10753 Falls Road, Pavilion II, Suite 455

Lutherville, MD 21093

phone: 410-583-2802

fax: 410-583-2842

The Wilmer Ophthalmological Institute

The Johns Hopkins University School of Medicine

600 N. Wolfe Street

Baltimore, MD, 21287

phone: (410) 955-5490

fax: (410) 614-9172

About Wilmer Eye Institute

The Wilmer Eye Institute has long been recognized for bringing together ophthalmologists consistently ranked by their peers as among the finest internationally, with a specially trained and highly experienced team of nurses cited by patients for their knowledge, responsiveness, and sensitivity. Working together, they have established and refined a flexible approach for delivering state-of-the-art ophthalmic care - and created the Wilmer Eye Care Pavilion as the optimal setting for that approach. We welcome you to visit us. For more information about the Wilmer Eye Institute, please visit: www.hopkinsmedicine.org/wilmer.

# # #



Contact Information James J. Salz, M.D.

Trusted LASIK Surgeons, Inc.

http://www.TrustedLASIKSurgeons.com

+1 (800) 483-8028

Online Marketing Dept.

LanceThink Media

http://www.LanceThinkMedia.com

+1 (800) 846-6208



Wednesday, February 18, 2009

North Carolina Company Announces First Chronic Pain Control Unit Combining Two Most Used Forms of Electrotherapy For Chronic Pain - Tens & Interferential

North Carolina Company Announces First Chronic Pain Control Unit Combining Two Most Used Forms of Electrotherapy For Chronic Pain - Tens & Interferential

Portable device can be used in home, rather than hospital, and can be worn for treatment anytime, anywhere, including work.

(PRWEB) January 13, 2009 -- MedFaxx (http://www.medfaxxinc.com) has announced the release of the first FDA approved, insurance reimbursable unit that combines the most used form of electrotherapy in the world clinically for chronic pain, interferential with TENS (transcutaneous electrical nerve stimulation) which is the most used form of electrotherapy for chronic pain outside the clinic. The Infrex Plus (http://www.painreductiontherapy.com/infrex1.php) unit means those individuals suffering from agonizing pain can now self-treat without the use of narcotics, at home or work, on an as needed basis.

Historically interferential (8,000+ pulses per second) was only used for patients in a clinical setting. Each session cost the patient or insurance company for each treatment. The benefit of interferential is immediate pain relief (http://www.painreductiontherapy.com/infrex1.php) that provides 'carryover' pain relief that can last for hours, days, and sometimes weeks.

With the release of the new combination unit a patient can treat at home, work, or wherever pain starts, whenever it starts. The patient is no longer dependent upon scheduling an appointment, being denied treatment by the insurance company, or having to take time off from work to get relief. The new unit is small enough, yet powerful enough, for the patient to wear/carry and use during breaks or on the job to self treat to.

The overall savings from missing work will be in the mega millions of dollars for the employer and employee.

Bob Johnson of MedFaxx Inc. said: "The Infrex Plus unit means those individuals suffering from agonizing pain can now self-treat without the use of narcotics, at home or work, on an as needed basis."

The breakthrough is the result of new-patented engineering technology that allows the use of portable, rechargeable batteries that can sustain enough energy for the patient to receive up to two treatments using only the battery system. In most settings, it is preferred the unit be plugged into a wall outlet with the AC adaptor. The engineering efficiency of using either batteries or AC adaptor means more patients can stay on the job, be active with their families, and not worry about the onset of crippling pain.

Interferential is not new. It's been around since 1951 but has been regarded as "experimental" by Medicare even though it is the most effective form of electrotherapy for pain in the world. Due to the classification, Medicare patients had to be treated with interferential only in clinical settings. Medicare would deny the purchase of an interferential unit, even though the patient's pain was resolved. The new Infrex Plus unit solved this problem by combining a Medicare approved unit, TENS, with the interferential mode into one unit so a patient can choose which treatment is best and have the unit paid for by the insurance company, including Medicare.

The overall savings to the U.S. health care system will be significant. Patients can obtain relief without having to go to clinics. This dramatically reduces the cost of chronic pain management to patients, insurance companies, and Medicare.

The company, MedFaxx, offers a free trial of the Infrex Plus unit, for the patient to determine its efficacy before any purchase is made. During the trial, the company consults with the insurance company to make sure coverage is provided and if not MedFaxx will work with any patient to insure the patient is treated.

For over 30+ years the company has operated on the premise that no deserving patients will be denied access to its equipment due to lack of funds. As the only unit approved by the FDA., a prescription is required from a licensed medical doctor before the unit can be sent for the free trial. The company works with the patient and doctor to facilitate this process. For a free trial visit here: http://www.painreductiontherapy.com/infrex1.php

More information can be obtained by visiting the website, http://www.medfaxxinc.com or by calling Bob Johnson at 800-937-3993 - 9 a.m. - 5 p.m. EST.

###



Contact Information Bob Johnson

MedFaxx Inc.

http://www.medfaxxinc.com

800-937-3993